The maker of the only drug approved to reduce the risk of premature labor in the US wants to pull it off the market — gradually — years after research raised questions about how well it works https://t.co/gxVOhp2rVs— Bloomberg (@business) March 8, 2023
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


